Last reviewed · How we verify
TIMOFÉROL®
Timoférol is a thymic extract that stimulates immune function by promoting T-cell maturation and differentiation.
Timoférol is a thymic extract that stimulates immune function by promoting T-cell maturation and differentiation. Used for Immunodeficiency disorders, Recurrent infections, Immune system support in immunocompromised patients.
At a glance
| Generic name | TIMOFÉROL® |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Drug class | Thymic extract / Immunomodulator |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Mechanism of action
Timoférol is derived from thymic tissue and acts as an immunomodulator by enhancing thymic hormone activity. It promotes the development and maturation of T lymphocytes, thereby strengthening cellular immunity. This mechanism makes it useful in conditions where immune function is compromised or needs augmentation.
Approved indications
- Immunodeficiency disorders
- Recurrent infections
- Immune system support in immunocompromised patients
Common side effects
- Local injection site reactions
- Mild fever
- Allergic reactions
Key clinical trials
- Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- TIMOFÉROL® CI brief — competitive landscape report
- TIMOFÉROL® updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI